基因编码的SpyTag通过SpyCatcher-Fused Ligands实现模块化AAV重定位,用于针对性基因传递
Anja Armbruster1,2,3, Maximilian Hörner2,3, Hanna J Wagner2,3
1INM - Leibniz Institute for New Materials, Saarbrücken 66123, Germany.
ACS synthetic biology
|December 22, 2025
概括
这项研究引入了一个模块化平台,用于使用SpyTag/SpyCatcher系统重新定位腺相关病毒 (AAV) 载体. 这种创新方法使得基因疗法能够精确地向癌细胞,提高了安全性和有效性.
科学领域:
- 分子生物学分子生物学
- 基因治疗 基因治疗
- 生物技术是生物技术.
背景情况:
- 由于安全性和生产可扩展性,复合腺相关病毒 (rAAV) 载体是体内基因治疗的关键.
- 目前的rAAV重定位方法通常需要广泛的囊体修饰,并限制连接体选择.
研究的目的:
- 开发一个模块化的rAAV重定位平台,使用SpyTag/SpyCatcher系统进行特定站点的连接.
- 使用这个新的平台来证明精确的癌细胞向和治疗性基因传递.
主要方法:
- 将SpyTag/SpyCatcher系统的遗传集成到AAV2囊中.
- 使用SpyCatcher融合的准配体 (DARPins) 的AAV的组装后功能化.
- 针对性转导和治疗性基因传递的体外和体内验证.
主要成果:
- 在生理条件下,成功地将连接体与AAV体的特定位点共价合.
- 对表达EGFR,EpCAM和HER2的癌细胞系的高特异性转导,具有最小的脱效应.
- 通过自杀基因传递证明了治疗疗效,导致选择性癌细胞杀死.
结论:
- 在不改变载体基因组或生产的情况下,SpyTag/SpyCatcher平台提供了一种多功能和快速的rAAV重定位方法.
- 这种方法支持多样化和复杂的配体,促进基因治疗的高通量临床前评估.
- 该模块化平台扩大了rAAV在治疗和研究环境中用于精确基因传递的应用.
关键词:
美国航空航天公司的体工程.在AAV重定位的重定位.在DARP中,insins是模块化基因传递,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyCatcher,SpyTag/SpyTag/SpyCatcher,SpyTag/SpyTag/SpyTag自杀基因疗法基因疗法相关概念视频
Conservative Site-specific Recombination and Phase Variation
6.6K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.6K
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
Tagging and Fusion Proteins
8.3K
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
8.3K


